These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28391334)

  • 21. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
    Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunopathologic co-localization of MPO, IgG, and C3 in glomeruli in human MPO-ANCA-associated glomerulonephritis.
    Kawashima S; Arimura Y; Sano K; Kudo A; Komagata Y; Kaname S; Kawakami H; Yamada A
    Clin Nephrol; 2013 Apr; 79(4):292-301. PubMed ID: 23537682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
    Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
    Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
    Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
    Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Weiner M; Bjørneklett R; Hrušková Z; Mackinnon B; Poulton CJ; Sindelar L; Mohammad AJ; Eriksson P; Gesualdo L; Geetha D; Crnogorac M; Jayne D; Hogan SL; Geddes C; Tesar V; Aasarød K; Segelmark M
    Nephrol Dial Transplant; 2019 Feb; 34(2):301-308. PubMed ID: 29718465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
    Bornstein G; Ben-Zvi I; Furie N; Grossman C
    Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis.
    Niles JL; Pan GL; Collins AB; Shannon T; Skates S; Fienberg R; Arnaout MA; McCluskey RT
    J Am Soc Nephrol; 1991 Jul; 2(1):27-36. PubMed ID: 1655091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.
    Franssen CF; Huitema MG; Muller Kobold AC; Oost-Kort WW; Limburg PC; Tiebosch A; Stegeman CA; Kallenberg CG; Tervaert JW
    J Am Soc Nephrol; 1999 Jul; 10(7):1506-15. PubMed ID: 10405206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANCA-associated pauci-immune glomerulonephritis: always pauci-immune?
    Scaglioni V; Scolnik M; Catoggio LJ; Christiansen SB; Varela CF; Greloni G; Rosa-Diez G; Soriano ER
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):55-58. PubMed ID: 28229825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.
    Zhao L; David MZ; Hyjek E; Chang A; Meehan SM
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination.
    Hakroush S; Tampe B
    Front Immunol; 2021; 12():762006. PubMed ID: 34659268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review.
    Bele D; Kojc N; Perše M; Černe Čerček A; Lindič J; Aleš Rigler A; Večerić-Haler Ž
    BMC Nephrol; 2020 Jan; 21(1):40. PubMed ID: 32005179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of Complement C4 Deposits Localized to Distinct Vascular Compartments in ANCA-Associated Renal Vasculitis.
    Hakroush S; Kluge IA; Baier E; Tampe D; Tampe B
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria.
    Xu PC; Chen T; Gao S; Hu SY; Wei L; Yan TK
    Ren Fail; 2018 Nov; 40(1):554-560. PubMed ID: 30278797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis.
    Damoiseaux JG; Slot MC; Vaessen M; Stegeman CA; Van Paassen P; Tervaert JW
    J Clin Immunol; 2005 May; 25(3):202-8. PubMed ID: 15981084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
    Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
    Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal neutrophils infiltration in antineutrophil cytoplasmic antibodies-negative pauci-immune crescentic glomerulonephritis.
    Xing GQ; Chen M; Liu G; Wang SX; Zhao MH
    Am J Med Sci; 2010 Dec; 340(6):474-80. PubMed ID: 21119331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.